Virtual Reality for Palliative Care
Phase-Based Progress Estimates
Effectiveness
Safety
Mayo Clinic Florida, Jacksonville, FL
Palliative Care
Virtual Reality - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The purpose of this study is to assess whether virtual reality technology can reduce anxiety, depression, and emotional distress screening scores in palliative care patients.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Baseline, post-intervention approximately 30 minutes
Baseline, post-intervention approximately 30 minutes
Change in anxiety
Change in emotional distress
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Virtual reality intervention in palliative care patients
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Virtual Reality · No Placebo Group · N/A
Virtual reality intervention in palliative care patients
Behavioral
Experimental Group · 1 Intervention: Virtual Reality · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1550
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post-intervention approximately 30 minutes
Closest Location: Mayo Clinic Florida · Jacksonville, FL
2007First Recorded Clinical Trial
1 TrialsResearching Palliative Care
87 CompletedClinical Trials
Who is running the clinical trial?
Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,686,141 Total Patients Enrolled
5 Trials studying Palliative Care
130,271 Patients Enrolled for Palliative Care
Chimere Bruning, PA-CPrincipal InvestigatorMayo Clinic
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have a terminal or end-stage condition with an expected prognosis of a year or less.
You are an established palliative care patient.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments